- Home
- DVA vs PSO Comparison
DVA vs PSO Comparison
Compare DVA & PSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- PSO
- Stock Information
- Founded
- DVA 1994
- PSO 1844
- Country
- DVA United States
- PSO United Kingdom
- Employees
- DVA N/A
- PSO N/A
- Industry
- DVA Misc Health and Biotechnology Services
- PSO Books
- Sector
- DVA Health Care
- PSO Consumer Discretionary
- Exchange
- DVA Nasdaq
- PSO Nasdaq
- Market Cap
- DVA 9.7B
- PSO 9.6B
- IPO Year
- DVA 1995
- PSO 2000
- Fundamental
- Price
- DVA $137.82
- PSO $14.17
- Analyst Decision
- DVA Hold
- PSO
- Analyst Count
- DVA 2
- PSO 0
- Target Price
- DVA $162.00
- PSO N/A
- AVG Volume (30 Days)
- DVA 701.0K
- PSO 480.9K
- Earning Date
- DVA 10-28-2025
- PSO 01-01-0001
- Dividend Yield
- DVA N/A
- PSO 2.18%
- EPS Growth
- DVA 8.72
- PSO 31.65
- EPS
- DVA 10.20
- PSO 0.90
- Revenue
- DVA $13,161,328,000.00
- PSO $4,822,578,436.00
- Revenue This Year
- DVA $5.96
- PSO N/A
- Revenue Next Year
- DVA $3.54
- PSO $9.79
- P/E Ratio
- DVA $13.47
- PSO $15.81
- Revenue Growth
- DVA 5.09
- PSO N/A
- 52 Week Low
- DVA $126.07
- PSO $13.27
- 52 Week High
- DVA $179.60
- PSO $17.90
- Technical
- Relative Strength Index (RSI)
- DVA 51.25
- PSO 39.31
- Support Level
- DVA $135.04
- PSO $14.04
- Resistance Level
- DVA $137.29
- PSO $14.30
- Average True Range (ATR)
- DVA 2.88
- PSO 0.12
- MACD
- DVA 0.26
- PSO -0.06
- Stochastic Oscillator
- DVA 54.32
- PSO 14.61
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About PSO Pearson Plc
Pearson PLC listed in the U.K., is an educational provider. The company has been divesting non-core businesses such as the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider. While Pearson's primary activity centers on higher education, the firm also operates in providing clinical assessments, professional certification, and testing.